Cookies on this website
We use cookies to ensure that we give you the best experience on our website. If you click 'Continue' we'll assume that you are happy to receive all cookies and you won't see this message again. Click 'Find out more' for information on how to change your cookie settings.

Researchers at Oxford University have launched a pioneering project to tackle crippling bone pain suffered by thousands of cancer patients.

An estimated 30,000 people every year develop this cancer-induced pain from a destructive and hugely debilitating bone disease caused by their cancers.

It affects people with primary bone tumours, bone marrow cancers such as multiple myeloma and other forms, such as breast and prostate cancer, that commonly spread to bone.

Our goal is to identify and understand pain-related changes in patients with cancer-induced bone disease so that new approaches to target this pain can be developed. - Dr Claire Edwards, Nuffield Department of Surgical Sciences

Dr Claire Edwards is leading the Oxford research project which is believed to be the first of its kind. She said: 'The major clinical feature of this cancer-induced bone disease is significant and life-altering bone pain but it’s the thing that we understand least.

'We believe that tumour cells increase the expression of molecules that promote pain. Our goal is to identify and understand pain-related changes in patients with cancer-induced bone disease so that new approaches to target this pain can be developed.'

Not only is little understood about the causes of the acute bone pain but it is also very difficult to manage.

The Oxford project is being funded by Orthopaedic Research UK (ORUK), one of the country's leading charities working to improve the lives of people with bone and joint disease and injury.

ORUK Chief Executive Dr Arash Angadji said: 'Cancer-induced bone pain is a devastating and debilitating feature of tumour growth within bones.

'Surprisingly, despite its major clinical impact, there is limited research in this area and a poor understanding of how and why the pain develops.

'This research will be a key step in the goal of developing new, safe and effective approaches to managing cancer induced bone pain which will improve the quality of lives of so many people.'

Similar stories

Oxford's largest ever study into varicose veins shows need for surgery is linked to genetics

Varicose veins are a very common manifestation of chronic venous disease, affecting over 30% of the population in Western countries. In America, chronic venous disease affects over 11 million men and 22 million women aged 40–80 years old. Left untreated it can escalate to multiple health complications including leg ulcers and ultimately amputations. A new international study by Oxford researchers published on 2 June 2022 in Nature Communications establishes for the first time, a critical genetic risk score to predict the likelihood of patients suffering with varicose veins to require surgery, as well as pointing the way towards potential new therapies.

New reporting guidelines developed to improve AI in healthcare settings

New reporting guidelines, jointly published in Nature Medicine and the BMJ by Oxford researchers, will ensure that early studies on using Artificial Intelligence (AI) to treat real patients will give researchers the information needed to develop AI systems safely and effectively.

Results of the REF 2021: congratulations and thank you

Today, the UK funding bodies have published the results of the UK’s most recent national research assessment exercise, the Research Excellence Framework (REF) 2021.

Blog posts

Oxford MedSci goes silver: 10 Years of Athena SWAN

The Medical Sciences Division is celebrating 10 years since its first Athena Swan bronze application, and the first year in which all 16 of its departments have achieved a silver award. The silver award recognises commitment to gender equality, understanding culture and context, and more. Read about our department’s hard work and innovation.

Lights, camera, action! My journey into video production

Dr Hannah McGivern provides a 'behind-the-scenes' account of her experience producing the video 'Journey of a QUOD Sample: Donating to Transplant Research', supported by the funds from the University of Oxford Public Engagement with Research (PER) Seed Fund.

Mentoring in practice

NDS has launched a new, interdepartmental mentoring scheme called RECOGNISE. In this podcast, Gemma Horbatowski (HR Advisor) interviews Monica Dolton (Programme Manager and Research Project Manager) about her experiences of mentor-mentee relationships.